Table 4.
Subgroup analysis for screening colonoscopy indication
| Reasons for colonoscopy | Single Dose (n=120) | Split Dose (n=120) | ||||
|---|---|---|---|---|---|---|
| Adequate Bowel Preparation | P | Adequate Bowel Preparation | P | |||
| Yes n (%) | No n (%) | Yes n (%) | No n (%) | |||
| History of polyps | 1 (25.0) | 3 (75.0) | 0.148 | 11 (84.6) | 2 (15.4) | 0.632 | 
| Screening (no personal history of polyps or cancer) | 12 (70.6) | 5 (29.4) | 0.592 | 15 (93.8) | 1 (6.3) | 1.000 | 
| Change in bowel habits | 26 (60.5) | 17 (39.5) | 0.844 | 34 (79.1) | 9 (20.9) | 0.013 | 
| Inflammatory bowel disease | 19 (82.6) | 4 (17.4) | 0.032 | 17 (94.4) | 1 (5.6) | 0.689 | 
| Rectal bleeding | 10 (52.6) | 9 (47.4) | 0.439 | 18 (90.0) | 2 (10.0) | 1.000 | 
| Cancer surveillance (follow-up evaluation) | 2 (50.0) | 2 (50.0) | 0.630 | 5 (100) | 0 (0) | 1.000 | 
| Anemia | 4 (44.4) | 5 (55.6) | 0.293 | 8 (100) | 0 (0) | 0.597 | 
| Others | 10 (62.5) | 6 (37.5) | 1.000 | 19 (86.4) | 3 (13.6) | 0.704 |